Major Fund Stock Sales for Yingli Green Energy Holding Co. Ltd.
Insiders are generally long-term investors due to restriction in making short-term profits. In contrast, wealth management institutions always have short-term investment. Wall St. Watchdog reveals information regarding the insiders and institutions which recently decreased stock shares of Yingli Green Energy Holding Co. Ltd. (NYSE:YGE).
SEC data indicate that these institutions significantly reduced their stock shares of Yingli Green Energy Holding Co. Ltd. in Q3 2011:
KEYWISE CAPITAL MANAGEMENT LTD: On 06/30/2011, held 4,076,230 shares, worth $37,542,078. On 09/30/2011, held 0 shares.
CALAMOS ADVISORS LLC: On 06/30/2011, held 2,700,000 shares, worth $24,867,000. On 09/30/2011, held 0 shares.
CITADEL ADVISORS LLC: On 06/30/2011, held 2,223,355 shares, worth $20,477,100. On 09/30/2011, held 0 shares.
PICTET ASSET MANAGEMENT LTD: On 06/30/2011, held 1,224,924 shares, worth $11,281,550. On 09/30/2011, held 0 shares.
FMR LLC: On 06/30/2011, held 560,300 shares, worth $5,160,363. On 09/30/2011, held 0 shares.
About the company: Yingli Green Energy Holding Company Limited designs, manufactures and sells PV modules. The Company also designs, assembles, sells and installs PV systems that are connected to an electricity transmission grid or those that operate on a stand-alone basis.
Competitors to Watch: Trina Solar Limited (NYSE:TSL), Suntech Power Hldgs. Co., Ltd. (NYSE:STP), JA Solar Hldgs. Co., Ltd. (NASDAQ:JASO), SunPower Corporation (NASDAQ:SPWRA), First Solar, Inc. (NASDAQ:FSLR), China Sunergy Co., Ltd. (NASDAQ:CSUN), LDK Solar (NYSE:LDK), JinkoSolar Holding Co., Ltd. (NYSE:JKS), Total (NYSE:TOT), Chevron (NYSE:CVX), ExxonMobil (NYSE:XOM), BP plc (NYSE:BP) and Ascent Solar Tech., Inc. (NASDAQ:ASTI).
(Note: Data regarding Yingli Green Energy Holding Co. Ltd.’s stock holdings are sourced from whalewisdom.com. All data are assumed to be accurate.)
Improve Your 2011 Financial Health: Join the winning team of stock pickers with Wall St. Cheat Sheet’s acclaimed premium newsletter>>
To contact the reporter on this story: Dave Friedman at email@example.com
To contact the editor responsible for this story: Damien Hoffman at firstname.lastname@example.org